"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
| Descriptor ID |
D011433
|
| MeSH Number(s) |
D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propranolol" by people in Profiles.
-
Propranolol as therapy for cerebral cavernous malformations: a cautionary note. J Transl Med. 2022 04 05; 20(1):160.
-
Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models. J Clin Invest. 2021 02 01; 131(3).
-
SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol). Med Hypotheses. 2020 Nov; 144:110039.
-
Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas. Pediatr Dermatol. 2018 Jul; 35(4):e233-e234.
-
Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series. Pediatrics. 2016 09; 138(3).
-
Beta-adrenergic Blockade at Memory Encoding, but Not Retrieval, Decreases the Subjective Sense of Recollection. J Cogn Neurosci. 2016 06; 28(6):895-907.
-
ß2-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. J Clin Invest. 2014 Jul; 124(7):2935-46.
-
Serendipity: translational research, high quality care, and the children's hospital. Jay and Margie Grosfeld Lecture. J Pediatr Surg. 2014 Jan; 49(1):19-24.
-
Novel use of propranolol for management of pain in children with vertebral hemangioma: report of two cases. Childs Nerv Syst. 2013 May; 29(5):855-60.
-
Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010 Apr; 120(4):676-81.